Migraine Trial, Recruiting (NCT06504537)

Migraine Trial, Recruiting NCT06504537 Sponsor: Riphah International University Condition: Migraine

Printed from Voxsanity (voxsanity.com.au) — NCT06504537 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Migraine

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of any gender are eligible
People between 18 and 65 years old
People who have been diagnosed with migraine without aura (migraine without visual disturbances or other warning signs before the headache)
People whose migraines include nausea or vomiting, along with sensitivity to light or sound
People who have had one-sided headaches at least once a week for the past 3 or more months
People whose migraines meet the internationally recognised diagnostic guidelines known as ICHD-3 criteria (confirm with trial site)

Who may not be able to join:

People who have a condition present from birth affecting the bones or structure of the neck
People whose neck is unable to perform a specific movement test called the flexion-rotation test (confirm with trial site)
People who have meningitis (infection or inflammation around the brain) or deep vein thrombosis (a blood clot in a deep vein)
People who have a type of headache other than migraine
People whose headaches are caused by a trauma or injury to the neck

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: hira jabeen, Riphah International University

Phone: 0323-4116506

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06504537

Sponsor: Riphah International University

Phase: Not Applicable

Status: Recruiting

Condition: Migraine

Trial contact: 0323-4116506

More information: https://clinicaltrials.gov/study/NCT06504537

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of any gender are eligible
People between 18 and 65 years old
People who have been diagnosed with migraine without aura (migraine without visual disturbances or other warning signs before the headache)
People whose migraines include nausea or vomiting, along with sensitivity to light or sound
People who have had one-sided headaches at least once a week for the past 3 or more months
People whose migraines meet the internationally recognised diagnostic guidelines known as ICHD-3 criteria (confirm with trial site)

Who may not be able to join:

People who have a condition present from birth affecting the bones or structure of the neck
People whose neck is unable to perform a specific movement test called the flexion-rotation test (confirm with trial site)
People who have meningitis (infection or inflammation around the brain) or deep vein thrombosis (a blood clot in a deep vein)
People who have a type of headache other than migraine
People whose headaches are caused by a trauma or injury to the neck

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Riphah International University

Registry

ClinicalTrials.gov

Start date

1 January 2024

Est. completion

30 July 2024

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

International Classification of Headache Disorders (ICHD-3)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov